AcuCort AB (publ) (XSAT: ACUC)
Health Care · Pharmaceuticals · SE
Skr0.54
-0.74% today · -9.2% 1Y
AcuCort AB (publ) (XSAT: ACUC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.47M.
Over the last twelve months the share price has lost 9.2%, trading between 0.40 and 0.95.
Tweenvest scores AcuCort AB (publ) across four factors: quality 32/100, value 47/100, growth 85/100. Its strongest factor is growth.
ACUC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.47M
- Revenue (TTM)
- $289.00K
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 1.38
- 52-week high
- Skr0.95
- 52-week low
- Skr0.40
- Avg volume (3M)
- —
- Shares outstanding
- 234.44M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.36 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.50 | +0.13% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.